TGF-β1 modulates temozolomide resistance in glioblastoma via altered microRNA processing and elevated MGMT

Abstract

Our results reveal an underlying mechanism by which TGF-β1 confers temozolomide resistance. Furthermore, our findings suggest that a novel combination of temozolomide with a TGF-β inhibitor may serve as an effective therapy for glioblastomas.